Treace Medical Concepts I... (TMCI)
undefined
undefined%
At close: undefined
7.79
-0.13%
After-hours Jan 06, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -49.53M -42.81M -20.55M -3.67M -4.26M
Depreciation & Amortization 5.35M 2.13M 685.00K 1.21M 793.00K
Stock-Based Compensation 17.35M 8.11M 3.41M 919.00K 815.00K
Other Working Capital 6.24M 9.39M 4.19M 1.04M 3.76M
Other Non-Cash Items 1.99M 7.73M 176.00K 221.00K 147.00K
Deferred Income Tax n/a n/a 419.00K 2.14M 145.00K
Change in Working Capital -9.74M -5.81M -1.33M -5.32M -5.31M
Operating Cash Flow -34.58M -30.65M -17.19M -4.49M -7.67M
Capital Expenditures -11.46M -14.84M -2.71M -1.07M -1.21M
Acquisitions -20.00M 61.68M n/a n/a n/a
Purchase of Investments -169.87M -63.41M n/a n/a n/a
Sales Maturities Of Investments 120.02M 1.73M n/a n/a n/a
Other Investing Acitivies n/a -61.68M n/a n/a n/a
Investing Cash Flow -81.30M -76.52M -2.71M -1.07M -1.21M
Debt Repayment n/a 19.61M n/a 11.32M 20.00M
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies 3.73M 1.20M 107.65M 185.00K -261.00K
Financial Cash Flow 109.38M 20.81M 107.65M 11.50M 19.74M
Net Cash Flow -6.49M -86.36M 87.75M 5.94M 10.86M
Free Cash Flow -46.03M -45.49M -19.90M -5.56M -8.88M